Universal Biosensors [ASX:UBI]

UBIUniversal Biosensors

About Universal Biosensors

Universal Biosensors (ASX:UBI) is a global leader in the development and commercialisation of rapid, accurate and affordable biosensor technologies. The company's operations are focused on the development and commercialisation of its two proprietary biosensor platforms, Xprecia and Sentia. Xprecia is a rapid diagnostic platform that can be used to detect a wide range of diseases and health conditions, including COVID-19, influenza, and diabetes.

What is UBI known for?

Snapshot

Public AU

Ownership

2001

Year founded

Employees

Victoria, Australia

Head office

1 of 170

AU Rank

Unknown

Sector

N/A

Sector rank

Loading Map...

Operations

All Locations

Australia

Produtos e/ou serviços de Universal Biosensors

Sentia Analyzer: Assesses key wine components on-site, providing rapid test results in minutes. With its user-friendly touchscreen and extended battery life, it ensures convenience and efficiency in winery operations.
Xprecia Prime: A portable coagulation monitoring device, featuring a compact size, precise measurements, and user-friendly operation. It enables healthcare professionals to oversee vitamin K antagonist oral anticoagulation therapy at the point of care.
Hemostasis Reference Laboratory: Aids contract research organisations, central laboratories, early phase clinics, and academic researchers in clinical trial endeavours.
PETRACKR Veterinary Blood Glucose Monitoring System: A swift and precise blood glucose monitoring solution for cats and dogs, seamlessly integrated with the PETRACKR app for effortless tracking and reporting.

equipe executiva do Universal Biosensors

Mr. Salesh Balak B.A., C.A.Company Secretary & Corporate Advisor
Mr. Peter MullinMD, Finance Director, CFO, Company Secretary & Executive Director
Mr. Luke Cossins B.Sc., M.B.A.C.T.O
Mr. Keith SimsGlobal Marketing Director
Ms. Ann Chew B.Com., CPA, CIAHead of People Strategy & Culture